Techno Medical PCL
SET:TM
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
T
|
Techno Medical PCL
SET:TM
|
TH |
|
A
|
Asian Alliance International PCL
SET:AAI
|
TH |
Balance Sheet
Balance Sheet Decomposition
Techno Medical PCL
Techno Medical PCL
Balance Sheet
Techno Medical PCL
| Dec-2012 | Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||||
| Cash & Cash Equivalents |
21
|
28
|
15
|
38
|
118
|
45
|
79
|
150
|
171
|
156
|
100
|
72
|
44
|
42
|
|
| Cash |
21
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash Equivalents |
0
|
28
|
15
|
38
|
118
|
45
|
79
|
150
|
171
|
156
|
100
|
72
|
44
|
42
|
|
| Short-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
50
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Receivables |
108
|
110
|
137
|
186
|
203
|
261
|
252
|
207
|
215
|
206
|
222
|
252
|
267
|
286
|
|
| Accounts Receivables |
108
|
110
|
135
|
182
|
194
|
250
|
244
|
200
|
209
|
195
|
203
|
221
|
225
|
241
|
|
| Other Receivables |
0
|
0
|
2
|
4
|
9
|
11
|
9
|
7
|
6
|
11
|
19
|
31
|
42
|
45
|
|
| Inventory |
87
|
80
|
85
|
154
|
203
|
211
|
200
|
167
|
154
|
181
|
188
|
222
|
186
|
148
|
|
| Other Current Assets |
12
|
5
|
3
|
5
|
4
|
4
|
4
|
7
|
53
|
5
|
4
|
0
|
0
|
0
|
|
| Total Current Assets |
227
|
223
|
239
|
383
|
528
|
521
|
535
|
582
|
593
|
548
|
515
|
546
|
497
|
477
|
|
| PP&E Net |
50
|
98
|
94
|
103
|
124
|
138
|
142
|
156
|
124
|
277
|
393
|
416
|
389
|
373
|
|
| PP&E Gross |
50
|
98
|
94
|
103
|
124
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Accumulated Depreciation |
27
|
30
|
36
|
38
|
43
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Intangible Assets |
0
|
1
|
3
|
2
|
3
|
2
|
2
|
2
|
3
|
4
|
6
|
4
|
3
|
3
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
3
|
8
|
8
|
8
|
8
|
8
|
|
| Other Long-Term Assets |
16
|
19
|
21
|
34
|
46
|
48
|
49
|
40
|
12
|
5
|
9
|
10
|
10
|
9
|
|
| Total Assets |
293
N/A
|
341
+16%
|
357
+5%
|
522
+46%
|
701
+34%
|
710
+1%
|
728
+3%
|
780
+7%
|
736
-6%
|
841
+14%
|
930
+11%
|
983
+6%
|
908
-8%
|
870
-4%
|
|
| Liabilities | |||||||||||||||
| Accounts Payable |
40
|
45
|
61
|
76
|
90
|
75
|
77
|
100
|
48
|
60
|
75
|
81
|
84
|
48
|
|
| Accrued Liabilities |
58
|
41
|
12
|
12
|
13
|
30
|
27
|
23
|
30
|
38
|
44
|
0
|
0
|
0
|
|
| Short-Term Debt |
73
|
76
|
76
|
208
|
194
|
165
|
166
|
177
|
156
|
165
|
195
|
258
|
234
|
218
|
|
| Current Portion of Long-Term Debt |
5
|
12
|
13
|
12
|
10
|
12
|
13
|
13
|
15
|
5
|
20
|
17
|
18
|
19
|
|
| Other Current Liabilities |
14
|
10
|
15
|
20
|
12
|
2
|
5
|
3
|
4
|
7
|
1
|
37
|
31
|
32
|
|
| Total Current Liabilities |
190
|
185
|
178
|
327
|
319
|
285
|
289
|
315
|
253
|
275
|
335
|
393
|
367
|
318
|
|
| Long-Term Debt |
21
|
50
|
37
|
22
|
12
|
19
|
11
|
10
|
2
|
49
|
91
|
110
|
99
|
87
|
|
| Deferred Income Tax |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
2
|
2
|
2
|
|
| Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
25
|
59
|
57
|
50
|
40
|
35
|
|
| Other Liabilities |
0
|
9
|
11
|
13
|
13
|
15
|
14
|
9
|
10
|
11
|
14
|
17
|
20
|
14
|
|
| Total Liabilities |
211
N/A
|
244
+15%
|
226
-8%
|
362
+60%
|
344
-5%
|
319
-7%
|
314
-2%
|
333
+6%
|
289
-13%
|
394
+36%
|
498
+26%
|
572
+15%
|
528
-8%
|
456
-14%
|
|
| Equity | |||||||||||||||
| Common Stock |
23
|
23
|
23
|
23
|
140
|
154
|
154
|
154
|
154
|
154
|
154
|
154
|
154
|
154
|
|
| Retained Earnings |
59
|
74
|
108
|
137
|
33
|
52
|
76
|
108
|
110
|
109
|
94
|
74
|
42
|
76
|
|
| Additional Paid In Capital |
0
|
0
|
0
|
0
|
184
|
184
|
184
|
184
|
184
|
184
|
184
|
184
|
184
|
184
|
|
| Total Equity |
82
N/A
|
97
+19%
|
131
+36%
|
160
+22%
|
357
+122%
|
390
+9%
|
414
+6%
|
447
+8%
|
448
+0%
|
447
0%
|
432
-4%
|
412
-5%
|
380
-8%
|
414
+9%
|
|
| Total Liabilities & Equity |
293
N/A
|
341
+16%
|
357
+5%
|
522
+46%
|
701
+34%
|
710
+1%
|
728
+3%
|
780
+7%
|
736
-6%
|
841
+14%
|
930
+11%
|
983
+6%
|
908
-8%
|
870
-4%
|
|
| Shares Outstanding | |||||||||||||||
| Common Shares Outstanding |
51
|
51
|
51
|
51
|
308
|
308
|
308
|
308
|
308
|
308
|
308
|
308
|
308
|
205
|
|